Bank Of New York Mellon Corp Arcutis Biotherapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$10.23 - $17.14 $1.39 Million - $2.33 Million	136,155 New	136,155 $1.5 Billion
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $1.83 Million - $2.68 Million	131,373 New	131,373 $1.94 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $520,898 - $786,454	29,182 Added 30.58%	124,609 $2.38 Million
Q2 2022 Aug 15, 2022	SELL	$16.33 - $22.2 $15,007 - $20,401	-919 Reduced 0.95%	95,427 $2.03 Million
Q1 2022 May 11, 2022	SELL	$14.38 - $22.79 $16,925 - $26,823	-1,177 Reduced 1.21%	96,346 $1.86 Million
Q4 2021 Feb 11, 2022	BUY	$14.98 - $25.5 $36,835 - $62,704	2,459 Added 2.59%	97,523 $2.02 Million
Q3 2021 Nov 12, 2021	BUY	$19.28 - $27.1 $153,950 - $216,393	7,985 Added 9.17%	95,064 $2.27 Million
Q2 2021 Aug 11, 2021	BUY	$24.42 - $34.75 $4,346 - $6,185	178 Added 0.2%	87,079 $2.38 Million
Q1 2021 May 13, 2021	BUY	$24.47 - $36.98 $498,551 - $753,430	20,374 Added 30.63%	86,901 $2.51 Million
Q4 2020 Feb 09, 2021	BUY	$17.82 - $31.73 $176,703 - $314,634	9,916 Added 17.52%	66,527 $1.87 Million
Q3 2020 Nov 12, 2020	BUY	$23.44 - $32.28 $500,584 - $689,371	21,356 Added 60.58%	56,611 $1.66 Million
Q2 2020 Aug 12, 2020	BUY	$24.48 - $36.56 $273,466 - $408,411	11,171 Added 46.38%	35,255 $1.07 Million
Q1 2020 May 06, 2020	BUY	$18.5 - $36.9 $445,554 - $888,699	24,084 New	24,084 $717,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $825M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.